Description
GIVE YOUR PATIENT LESS TO FEAR WITH LESS NEEDLE, LESS PAIN, AND LESS CHANCE OF INTRAMUSCULAR INJECTION.
BD Ultra-FineTM 6mm insulin syringe is 25% shorter than the 8mm needle. This length is supported by recent recommendations published in Mayo Clinic Proceedings that advocate using the shortest needle first-line for all patient categories.1† Preferred by most patients over their current needle length, BD Ultra-FineTM 6mm insulin syringes provide an approximately 3x lower risk of intramuscular injection compared to an 8-mm needle.2,3‡
The latest clinical recommendations advocate the use of shorter needle lengths for all patients with diabetes.1 Approximately 8 times lower probability of intramuscular injection compared to a12.7mm needle.2 Intramuscular injection can be painful and may lead to low blood sugar.4
Notes
* When compared to longer and thicker insulin syringe needles
† Excluding safety syringes
‡ Calculations assume a needle inserted at 90° without a pinch-up technique in an adult population
References
- Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
- Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
- BD 6mm Insulin Syringe Voice of Customer Market Research Report, August 2017.
- Frid A, et al. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care. 1990;13(5):473-7
________________
PRODUCT FEATURES
- Safe, effective and less painful
- Designed to provide consistent and reliable subcutaneous delivery of insulin in the treatment of diabetes
